Ransomware payments saw their biggest ever drop in H2 2024, according to Chainalysis. The level of payments varied significantly year to year, with 2022 seeing a marked decrease to $655m compared to $1.07bn in 2021 and nearly $1bn in 2020. In 2023, payments surged back to $1.25bn. Researchers warned reliable figures are challenging due to factors including attackers inflating figures, victims not coming forward, and the stigma around ransomware.
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is
